Videos

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, offers advice for effectively being able to adjust plans.

How Leaders Can Foster Proactive and Reactive Change

In the second part of this roundtable discussion, key opinion leaders discuss the potential technological challenges surrounding RFID, and the likelihood of not only utilizing this tech at the item level but for product security purposes as well. 

Peer Exchange: RFID Technological Obstacles (Episode 2)

Articles

The CDMO’s offerings will now feature automated fill-finish. 

GBI Biomanufacturing Grows Drug Product Services 

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, comments on the specific technical and soft skills that are critical in order for pharma leaders and frontline employees to excel in an ever-changing industry landscape, while explaining why these skills are beneficial when it comes to being proactive in handling talent shortages.

Skills Needed to Thrive in the Evolving Industry Landscape

Ryplazim is considered the first and only FDA-approved therapy specifically for the PLGD-1 indication.

FDA Grants Kedrion's Bolognana Plant Approval for Production of PLGD-1 Treatment

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, outlines the steps that pharma leaders should keep in mind to when combatting supply chain issues.

Properly Preparing for Supply Chain Disruptions 

The CDMO's California facility welcomes new production suites, a revamp of its development labs, and more. 

Fujifilm Completes Cell Therapy Plant Expansion Project

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.

Key Challenges Facing the Pharma Industry in 2025

The media company utilized CMS data and worked with Medicare experts to pinpoint qualities that were highly valued to consumers.

US News Ranks Its Top Medicare Advantage and Part D Companies

The CDMO is investing $3.6 million toward boosting its advanced labeling, automated visual inspection, and fill-finish tech.